Custom cell culture media: when a custom formulation beats a catalogue cell culture medium, what changes when cell media are made to your own specification, and what to settle about ownership, lots and raw materials

Custom media is commissioned for one of three reasons: a catalogue formulation does not support the cells well enough, a component has to be removed for regulatory or supply reasons, or the volume makes a bespoke blend cheaper than a catalogue product. Only the first is a science question, and it is worth being clear which of the three is driving the project before starting. This page covers the decision, the format and the terms.

the FDA cGMP rule that applies once material is destined for a drug product
Part 211
the ICH guideline on deriving and characterising cell substrates
Q5D
good laboratory practice for nonclinical studies, 21 CFR
Part 58

Figures in this panel are the rules a contract biologics service is bought and audited against, named from the regulations and guidelines themselves and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a services index it has not measured.

Commissioning a formulation

  1. Be clear which problem you are solving. Performance, composition control and cost lead to different projects. A performance project needs a development programme with screening; a composition project may be a straightforward removal or substitution; a cost project is a procurement exercise on a formulation you already have.
  2. Liquid or powder. Liquid is convenient and heavy to ship and store, with a shorter shelf life. Powder stores far longer and needs water quality, mixing and filtration capability plus the validation that goes with them. Volume and in-house capability decide this rather than preference.
  3. Raw material sourcing and traceability. Ask where components originate, whether any are animal derived, and what traceability the provider holds. For anything that may become a regulated process, animal origin components are a question that will be asked and is far easier to avoid than to justify.
  4. Formulation ownership. Establish who owns the formulation and whether you can have it made elsewhere. A bespoke medium you do not own is a single-source dependency for the life of the process, which is a serious position for a programme that succeeds.
  5. Lot control and bridging. Agree lot sizes, retention samples and what happens when a component supplier changes. Media lot variation is a classic invisible cause of drifting culture performance, and it is only detectable if you kept a reference and recorded which lot produced which result.

Before commissioning, exhaust the catalogue

Modern catalogue media are extensively developed, and a supplement screen on an existing formulation solves many performance problems at a fraction of the cost and time of a custom development. Providers will often run that screen for you.

Where the catalogue genuinely fails, the development is worth doing properly with a defined success criterion agreed in advance. Media projects without a stated target tend to continue indefinitely.

Testing what arrives

Test each lot in your own culture against a retained reference lot before committing it to production or to a long experiment. Growth, viability and the product attributes you care about are the test, not the certificate alone.

Keep retention samples of every lot. They are the only way to investigate afterwards whether a change in culture behaviour came from the medium.

Common questions

When is custom cell culture media worth commissioning?
When catalogue formulations and a supplement screen genuinely fail to support the cells, when a component must be removed for regulatory or supply reasons, or when volume makes a bespoke blend cheaper. Exhaust the catalogue first.
Liquid or powder media?
Liquid for convenience at modest volumes; powder for long storage and large volumes, provided you have the water quality, mixing and filtration capability and the validation to match.
Who owns a custom formulation?
Whatever the contract says. If you do not own it or cannot have it made elsewhere, the medium is a single-source dependency for the life of the process.
How do I control media lot variation?
Test each new lot against a retained reference in your own culture, keep retention samples, and record which lot produced which result. Lot variation is otherwise invisible and easily mistaken for an experimental effect.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/custom-cell-culture-media/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices